ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Autism
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1627704
This article is part of the Research TopicResearch by Autistic Researchers: An “Insider’s View” into AutismView all articles
Altered Plasma Fatty Acids Composition in Autism Spectrum Disorder: A case-control study
Provisionally accepted
- 1Guizhou Provincial People's Hospital, Guiyang, China
- 2Minhang Hospital, Fudan University, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Due to the variability in clinical manifestations and the frequent diagnostic delays associated with autism spectrum disorder (ASD), interest in identifying fatty acids as potential biomarkers is increasing. Nonetheless, owing to inconclusive evidence, further investigation is needed. Objective: To explore the relationship between fatty acids and ASD risk and identify distinct fatty acid metabolites in children with ASD. Methods: Plasma fatty acid levels were tested in totally 131 participants (ages 2-6 and male-to-female ratio 2.5:1) with and without ASD using gas chromatography coupled to flame ionization detector and mass spectrometer (GC-FID/MS) technology. Between-group differences in each fatty acid and the omega-3 polyunsaturated fatty acid/arachidonic acid (AA) ratio were explored. We adjusted for covariates via multivariable models. The discriminatory sensitivity of meaningful fatty acids between ASD and control groups was assessed via receiver operating characteristic curve (ROC) analysis. Results: Two of 22 fatty acids significantly differed between children with ASD and typically developing children. Specifically, C20:46 (AA) (457.4±195.3 μmol/L vs. 493.3±111.9 umol/L, P=0.044) and C24:0 (34.7±7.9 μmol/L vs. 38.3±8.7 μmol/L, P=0.019) levels were significantly lower in the autism group than in the control group, whereas the alpha-linolenic acid (ALA)/AA ratio [0.13(0.10, 0.18) vs. 0.10(0.08, 0.15)] was significantly greater in children with autism than in those without. Potential interactive effects between AA, C24:0, ALA/AA and gastrointestinal syndromes were further observed. Biomarkers were assessed via ROC analysis, which revealed AA, C24:0 and ALA/AA AUC values of 0.60(0.50~0.70), 0.62(0.52~0.72) and 0.62 (0.52~0.71), respectively. Conclusions Fatty acid disturbance was observed among children with ASD, particularly in terms of AA, C24:0 and the ALA/AA ratio. These findings provide valuable insights into the underlying mechanisms of ASD and suggest that modulating fatty acid levels could serve as an intervention strategy.
Keywords: Autism Spectrum Disorder, Fatty Acids, saturated fatty acids, Unsaturated fatty acids, receiver operating characteristic curve
Received: 13 May 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Zhou, Liu, Zhang, Wang, Guo, Peng, Tai and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hao Zhou, Guizhou Provincial People's Hospital, Guiyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.